GS-441524 powder is a highly specialized form of an antiviral medication used to treat Feline Infectious Peritonitis (FIP), a serious and often fatal disease in cats caused by a mutation of the feline coronavirus. As an investigational drug, GS-441524 has shown considerable promise in clinical and practical settings for its ability to halt the progression of this previously untreatable disease.
Injectable Form: When reconstituted into an injectable solution, GS-441524 is typically administered subcutaneously. This route is particularly beneficial for cats with severe gastrointestinal symptoms, as it bypasses the digestive tract and ensures rapid systemic absorption.
Oral Suspension: Alternatively, the reconstituted powder can be given orally, either directly or mixed with food. This method is more convenient for long-term treatment, especially in a home care setting, and is often used for maintenance therapy after initial stabilization with injections.
Clinical studies and anecdotal evidence have demonstrated the efficacy of GS-441524 in treating various forms of FIP, including both the effusive (wet) and non-effusive (dry) forms. Many cats have shown significant improvement, with symptoms such as fever, weight loss, and lethargy resolving over time. In some cases, complete remission has been achieved, offering a new lease on life for cats that were once facing a grim prognosis.
| Property | Details |
|---|---|
| CAS Number | 1191237-69-0 |
| Grade | Pharmaceutcial Grade |
| Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
| Density | 1.84±0.1 G |
| Appearance | White Powder |
| Storage | Store At Cool Dry Place |
| Molecular Weight | 291.26 |
| Purity | 99.0% |
Diagnosing FIP is challenging and often involves a combination of clinical signs, laboratory tests, and ruling out other diseases. Common diagnostic steps include:
1. Blood tests: Elevated protein levels, high white blood cell count, and low albumin-to-globulin ratio.
2. Imaging: Ultrasound or X-rays to detect fluid accumulation.
3. Fluid analysis: Testing the fluid from the abdomen or chest for elevated protein levels and specific cell types.
4. Biopsy: Histopathological examination of affected tissues can provide a definitive diagnosis.
GS441524 is a medication used to treat feline infectious peritonitis (FIP). Below are the general guidelines for using GS441524 powder, but specific usage should be adjusted according to a veterinarian's instructions:
1. Dosage:
The typical dosage depends on the cat's weight and the severity of the condition. The recommended dosage is usually 4-6 mg/kg of body weight, but higher doses may be required for severe cases.
2. Preparation:
GS441524 powder needs to be dissolved in sterile water or another appropriate solvent. Preparation should be done in a clean, sterile environment to ensure the stability and effectiveness of the medication.
3. Injection:
The dissolved solution is usually administered via subcutaneous or intravenous injection. For subcutaneous injection, choose a soft skin area (such as the back or shoulder) and use a sterile syringe. Intravenous injection should be performed by a professional veterinarian.
4. Frequency and Duration:
Generally, the injection is given once daily for at least 12 weeks. During the treatment, regular blood tests and other diagnostic evaluations are necessary to monitor the treatment's effectiveness and adjust the dosage as needed.
5. Precautions:
Ensure all equipment (syringes, solvents, etc.) is sterile.
Avoid overdosing to prevent potential toxicity and side effects.
If any adverse reactions occur during treatment, contact a veterinarian immediately.
The specific method and dosage should be determined and adjusted by a veterinarian based on the cat's condition. Always consult a professional veterinarian and follow their instructions precisely when using GS441524 powder.
